Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 74 - Collaborative Drug Therapy Management › Subchapter D - Collaborative Drug Therapy Advisory Committee › Section XLV-7419 - Composition; Appointment

Current through Register Vol. 50, No. 6, June 20, 2024
A. The
					 advisory committee shall be composed of seven members, consisting of four
					 physicians and three pharmacists. These members shall include: one physician
					 designated by the Louisiana State University Health Sciences Center School of
					 Medicine in New Orleans; one physician designated by the Louisiana State
					 University Health Sciences Center School of Medicine in Shreveport, one
					 physician designated by the Tulane University Health Sciences Center School of
					 Medicine; one physician designated by the Louisiana State Medical Society; one
					 pharmacist who holds the academic degree of Doctor of Pharmacy designated by
					 the Xavier University of Louisiana College of Pharmacy; one pharmacist who
					 holds the academic degree of Doctor of Pharmacy designated by the University of
					 Louisiana at Monroe School of Pharmacy; and one pharmacist designated by the
					 Louisiana Board of Pharmacy. The president of the Louisiana State Board of
					 Medical Examiners or his/her designee may sit on the committee in an ex officio
					 capacity.
B. To be eligible for
					 appointment to the advisory committee each individual shall have maintained
					 residency and practiced their profession in the state of Louisiana for not less
					 than one year, hold the qualifications prescribed by this Chapter for those of
					 their respective professions who may wish to engage in collaborative drug
					 therapy management, and possess education, particular experience, advanced
					 training or other qualifications that the board may deem to be of value to the
					 advisory committee in the discharge of its duties and
					 responsibilities.
C. Each member of
					 the advisory committee shall be appointed by the board from among a list of one
					 or more qualified nominees for each position submitted to the board.
					 Accompanying each nominee shall be a personal resume or curriculum vitae for
					 the individual. In the event a designating entity does not submit nominees
					 within 90 days of the board's request the position or vacancy may be filled by
					 a physician or pharmacist designated by the board. Each member of the advisory
					 committee shall serve for a term of three years or until a successor is
					 appointed and shall be eligible for reappointment. With the exception of the
					 member designated by the Louisiana Board of Pharmacy, who shall serve at the
					 pleasure of that board, all members of the advisory committee shall serve and
					 be subject to removal at any time at the pleasure of the board. Members
					 appointed to fill a vacancy occurring other than by expiration of the
					 designated term shall serve for the unexpired term. Appointments to the
					 advisory committee shall be effective when made with respect to appointments
					 for unexpired terms and otherwise shall be effective as of the first day of the
					 month following the date of appointment.
D. The advisory committee shall meet not less
					 than once each calendar year, or more frequently as may be deemed necessary or
					 appropriate by a quorum of the advisory committee or by the board. The presence
					 of four members shall constitute a quorum. The advisory committee shall elect
					 from among its members a chairperson, a vice-chairperson and a secretary. The
					 chair or in the absence or unavailability of the chair the vice-chair, shall
					 call, designate the date, time and place of, and preside at meetings of the
					 advisory committee. The secretary shall record or cause to be recorded,
					 accurate and complete written minutes of all meetings of the advisory committee
					 and shall cause copies of the same to be provided to the board.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6),
						and
						37:1164(37).